EPI-743 for Freidreich’s Ataxia Point Mutations, Kelly Sullivan, Mary Freeman, Jessica D. Shaw, Clifton Gooch, Yangxin Huang, Matthew Klein, Guy Miller, Theresa Zesiewicz
Kelly L. Sullivan

EPI-743 Improves Motor Function and CNS Biomarkers in PD: Results From a Phase 2A Pilot Trial, Theresa A. Zesiewicz, Kevin Allison, Israt Jahan, Jessica A. Shaw, F. Murtagh, Tracy Jones, Clifton Gooch, Jason L. Salemi, Matthew Klein, Guy Miller, Kelly L. Sullivan
Kelly L. Sullivan

EPI-743 (Alpha-Tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia, Theresa A. Zesiewicz, Susan Perlman, Kelly L. Sullivan, Jason Salemi, Yangxin Huang, Charles Isaacs, Matthew Klein, Jessica Shaw, Clifton Gooch, David Lynch
Kelly L. Sullivan

EPI-743 (Alpha-Tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia, Theresa A. Zesiewicz, Susan Perlman, Kelly L. Sullivan, Yangxin Huang, Jason L. Salemi, Matthew Klein, Charles Isaacs, Clifton Gooch, Jessica Shaw, David Lynch
Kelly L. Sullivan

EPI-743 for Friedreichs Ataxia Patients with Point Mutations, Kelly L. Sullivan, Mary Freeman, Jessica Shaw, Clifton Gooch, Yangxin Huang, Matthew Klein, Guy Miller, Theresa A. Zesiewicz
Kelly L. Sullivan

EPI-743 Improves Motor Function and CNS Biomarkers in PD: Results From a Phase 2A Pilot Trial, Theresa A. Zesiewicz, Kevin Allison, Israt Jahan, Jessica Shaw, F. Murtagh, Tracy Jones, Clifton Gooch, Jason L. Salemi, Matthew Klein, Guy Miller, Kelly L. Sullivan
Kelly L. Sullivan

EPI-743 (Alpha-Tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia, Theresa A. Zesiewicz, Susan Perlman, Kelly L. Sullivan, Jason Salemi, Yangxin Huang, Charles Isaacs, Matthew Klein, Jessica Shaw, Clifton Gooch, David Lynch
Epidemiology Faculty Presentations

EPI-743 (Alpha-Tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia, Theresa A. Zesiewicz, Susan Perlman, Kelly L. Sullivan, Yangxin Huang, Jason L. Salemi, Matthew Klein, Charles Isaacs, Clifton Gooch, Jessica Shaw, David Lynch
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

EPI-743 for Freidreich’s Ataxia Point Mutations, Kelly Sullivan, Mary Freeman, Jessica D. Shaw, Clifton Gooch, Yangxin Huang, Matthew Klein, Guy Miller, Theresa Zesiewicz
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

EPI-743 Improves Motor Function and CNS Biomarkers in PD: Results From a Phase 2A Pilot Trial, Theresa A. Zesiewicz, Kevin Allison, Israt Jahan, Jessica Shaw, F. Murtagh, Tracy Jones, Clifton Gooch, Jason L. Salemi, Matthew Klein, Guy Miller, Kelly L. Sullivan
Epidemiology Faculty Presentations

EPI-743 Improves Motor Function and CNS Biomarkers in PD: Results From a Phase 2A Pilot Trial, Theresa A. Zesiewicz, Kevin Allison, Israt Jahan, Jessica A. Shaw, F. Murtagh, Tracy Jones, Clifton Gooch, Jason L. Salemi, Matthew Klein, Guy Miller, Kelly L. Sullivan
Department of Biostatistics, Epidemiology, and Environmental Health Sciences Faculty Publications

EPI-743 for Friedreichs Ataxia Patients with Point Mutations, Kelly L. Sullivan, Mary Freeman, Jessica Shaw, Clifton Gooch, Yangxin Huang, Matthew Klein, Guy Miller, Theresa A. Zesiewicz
Epidemiology Faculty Presentations